FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

22054711000001102: Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73100601000001115 Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73100701000001113 Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Is a Rivastigmine 4.5mg capsules 28 capsule true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has AMP Kerstipon 4.5mg capsules (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has specific active ingredient Rivastigmine tartrate true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Kerstipon 4.5mg capsules (Aspire Pharma Ltd) 28 capsule 4 x 7 capsules Has basis of strength substance Rivastigmine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start